Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...
Chaudhary Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya, Palampur, successfully concluded a two-day workshop on Molecular Biology and Recombinant DNA Technology at the Department of Veterinary ...
Newborn babies admitted to the hospital's neonatal intensive care unit (NICU) rely on the quick decisions and rapid action of the medical team responsible for them. DNA testing is critical to ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
Yes, you can pay $50,000 to clone a pet. But others are using the technology to rescue endangered species. This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that ...
Discover how scientists are harnessing the power of CRISPR to precisely edit DNA, revolutionizing medicine and ethics as they rewrite the very code of life. Pixabay, PublicDomainPictures CRISPR ...
This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...
ViaGen has successfully cloned endangered species like Przewalski’s horses. Elizabeth Arellano Photography/Courtesy Colossal Biosciences However, Colossal CEO Ben Lamm insists the move wasn’t ...
Two Texas-based biotechnology companies are joining forces on a mission to reverse extinction. Colossal Biosciences Inc., the Dallas-based genetics company that claimed to have brought back the dire ...
Local investigators working with cutting-edge technology and a Texas-based company are solving decades-old murders, identifying unknown remains and bringing closure to families who never expected ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...